About Michael Kaufman
Michael Kaufman is a director at Noveome Biotherapeutics.
Form D filings also name Michael Kaufman as a chief executive officer, MAK capital and director at Trailhead Biosystems.
Michael Kaufman first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Kaufman in the role, so the role may have started earlier or lasted longer.
Noveome Biotherapeutics, Inc.
Director
2023 – 2026 · Pittsburgh, PA
Develops experimental biologic treatments for infants with a serious intestinal disease and other patients.
Trailhead Biosystems Inc.
Chief Executive Officer, MAK Capital and director
2020 – 2026 · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
Key Colleagues at Startups
The people Michael Kaufman works with at each company, as listed on that company's latest Form D.
Noveome Biotherapeutics, Inc. · Form D, Aug 27, 2026
HH
Houman Hemmati
Board Member
EK
Eric Keller
Board Member/President
Ronald Poropatich
Board Member/Chairman of the Board
RL
Robert Langer
Director
Patrick Welch
CEO/Board Member
Larry Brown
Executive officer
Karin Potoka
Chief Medical Officer
Craig Nemiroff
Board Member
Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
HH
Houman Hemmati
Director
Wolfgang Hofmann
Board Member, Trailhead Biosystems
Craig Nemiroff
Managing Director, MAK Capital
David Llewellyn
President and Chief Executive Officer, director
Joshua Snow
Chief Commercial Officer
Jan Jensen
Board Member, Trailhead Biosystems
Divya Trivedi
Chief Operating Officer